OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased response
Bernarda Pschunder, Lucia Locati, Oriana López, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Bernarda Pschunder, Lucia Locati, Oriana López, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Showing 7 citing articles:
State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens
Matteo Ridelfi, Giulio Pierleoni, V. Fonseca, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access
Matteo Ridelfi, Giulio Pierleoni, V. Fonseca, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?
Maria Gabriella Matera, Carlo Capristo, Vito de Novellis, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
Maria Gabriella Matera, Carlo Capristo, Vito de Novellis, et al.
Expert Review of Anti-infective Therapy (2025)
Closed Access
Bioengineered ClearColi™-derived outer membrane vesicles displaying CT26 neoepitopes as potent vaccine adjuvants against colon carcinoma in a preventive mouse model
Elham Sharif, Taranom Mobasheri, Elham Mohit
Vaccine (2025) Vol. 53, pp. 127088-127088
Closed Access
Elham Sharif, Taranom Mobasheri, Elham Mohit
Vaccine (2025) Vol. 53, pp. 127088-127088
Closed Access
Highlights of the 14th International Bordetella Symposium
Kevin Munoz Navarrete, Kathryn M. Edwards, Kingston H. G. Mills, et al.
mSphere (2025)
Open Access
Kevin Munoz Navarrete, Kathryn M. Edwards, Kingston H. G. Mills, et al.
mSphere (2025)
Open Access
A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussis
Michelle Galeas‐Pena, Alec J. Hirsch, Erin Kuang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Michelle Galeas‐Pena, Alec J. Hirsch, Erin Kuang, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma
Elham Sharif, Navid Nezafat, Elham Mohit
International Immunopharmacology (2024) Vol. 143, pp. 113283-113283
Closed Access | Times Cited: 1
Elham Sharif, Navid Nezafat, Elham Mohit
International Immunopharmacology (2024) Vol. 143, pp. 113283-113283
Closed Access | Times Cited: 1
Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection
Erika Rudi, Elizabeth R. Gaillard, Daniela Bottero, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Erika Rudi, Elizabeth R. Gaillard, Daniela Bottero, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
